This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Ian Alfred Critchley: Innovator in Biomedical Research
Introduction
Ian Alfred Critchley is a notable inventor based in Crawley, GB. He has made significant contributions to the field of biomedical research, particularly in the development of innovative solutions to prevent bacterial adhesion in medical devices.
Latest Patents
Critchley holds two patents, with his latest focusing on a Fibronectin binding protein and monoclonal antibodies. This invention includes a monoclonal antibody (Mab) that binds to specific epitopes of a matrix binding protein. It also features an isolated D1-D4 polypeptide from Staphylococcus aureus Fbp. The primary application of this invention is in preventing the adhesion of gram-positive bacteria to extracellular matrix proteins on indwelling devices or to matrix proteins in wounds.
Career Highlights
Throughout his career, Critchley has been associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of bacterial interactions with human tissues.
Collaborations
Critchley has collaborated with notable colleagues, including Martin Karl Burnham and Ian Chopra, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Ian Alfred Critchley is a distinguished inventor whose work in biomedical research has the potential to significantly improve patient outcomes by addressing critical challenges in bacterial adhesion. His innovative patents reflect his commitment to advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile